Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Nalbuphine Allergy × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colonic Neoplasms 3 Chronic Pain 3 Cancer Pain 3 Supratentorial Neoplasms 2 Pain, Postoperative 2 Neoplastic Cells, Circulating 2 Neoplasms 2 Colorectal Neoplasms 2 Substance Withdrawal Syndrome 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Pain 1 Neoplasm, Residual 1 Nalbuphine Allergy 1 Ileus 1 Head and Neck Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Constipation 1 Breakthrough Pain 1 Brain Neoplasms 1 Agnosia 1 Age Problem 1 Abdominal Cancer 1

Interventions

Nalbuphine 1 Morphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05073744 2022-12-29

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Zhongda Hospital

Phase 4 Unknown

Nalbuphine Allergy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡